# Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

> **NCT05268692** · PHASE2,PHASE3 · RECRUITING · sponsor: **Kochi University** · enrollment: 500 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** GS
- **DRUG:** GnP

## Key facts

- **NCT ID:** NCT05268692
- **Lead sponsor:** Kochi University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05268692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05268692, "Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05268692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*